Insider · CIK 0001664801
Dyrness Albert D.
Reports to the SEC for 3 companies · NEW YORK, NY
Transactions
14
Companies
3
Filings
13
CIK
0001664801
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-02-09 | PURRHyperliquid Strategies IncA Award | — |
| 2025-12-02 | Sonnet BioTherapeutics Holdings, Inc.D Disposition to Issuer | — |
| 2025-12-02 | PURRHyperliquid Strategies IncJ Other | — |
| 2023-12-11 | Sonnet BioTherapeutics Holdings, Inc.A Award | — |
| 2023-07-11 | Sonnet BioTherapeutics Holdings, Inc.A Award | — |
| 2023-05-30 | Sonnet BioTherapeutics Holdings, Inc.P Purchase | +$10.9K |
| 2022-12-14 | Sonnet BioTherapeutics Holdings, Inc.A Award | — |
| 2021-12-15 | Sonnet BioTherapeutics Holdings, Inc.A Award | — |
| 2020-07-02 | Sonnet BioTherapeutics Holdings, Inc.A Award | — |
| 2020-06-11 | Sonnet BioTherapeutics Holdings, Inc.P Purchase | +$9,660.09 |
| 2020-04-01 | Sonnet BioTherapeutics Holdings, Inc.Warrant to Purchase Common StockA Award | — |
| 2020-04-01 | Sonnet BioTherapeutics Holdings, Inc.A Award | — |
| 2017-10-26 | OTLKOutlook Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2016-12-22 | OTLKOutlook Therapeutics, Inc. · Warrant (Right to Buy)P Purchase | — |
Recent filings
- 4Dyrness Albert D.0001193125-26-047187SEC(opens sec.gov)
- 4Dyrness Albert D.0001193125-25-330461SEC(opens sec.gov)
- 4Dyrness Albert D.0001493152-25-026062SEC(opens sec.gov)
- 4Dyrness Albert D.0001641172-25-019785SEC(opens sec.gov)
- 4Dyrness Albert D.0001493152-24-048956SEC(opens sec.gov)
- 4Dyrness Albert D.0001493152-23-019539SEC(opens sec.gov)
- 4Dyrness Albert D.0001493152-22-036313SEC(opens sec.gov)
- 4Dyrness Albert D.0001493152-22-009486SEC(opens sec.gov)
- 4Dyrness Albert D.0001493152-20-012568SEC(opens sec.gov)
- 4Dyrness Albert D.0001493152-20-011085SEC(opens sec.gov)
- 4Dyrness Albert D.0001493152-20-005838SEC(opens sec.gov)
- 4Dyrness Albert D.0001209191-17-058359SEC(opens sec.gov)
- 4Oncobiologics, Inc.0001209191-16-156825SEC(opens sec.gov)
Companies
Address
C/O HYPERLIQUID STRATEGIES INC 477 MADISON AVENUE, 22ND FLOOR
NEW YORK, NY, 10022